The post Solana Slides To Its Lowest Price At $93 appeared on BitcoinEthereumNews.com. Nov 05, 2025 at 17:21 // Price Solana (SOL) price have fallen below the moving average lines after being rejected at the $200 level. SOL price long-term prediction: bearish  The negative trend has broken below both the moving average lines and the current support level of $170. The cryptocurrency has reached a low of $151. However, the price indicator suggests that the altcoin will continue to decline. SOL is expected to break below the current support level of $170 and fall as low as $130. A retraced candle body tested the 38.2% Fibonacci retracement level. The retracement indicates that Solana will fall to the 2.618 Fibonacci extension, or the $93.24 low. Technical indicators Key supply zones: $220, $240, $260 Key demand zones: $140, $120, $100 Solana price indicator analysis The moving average lines continue to slope lower as the coin declines further. The resistance line for the price bars is the 21-day SMA barrier. The horizontal moving average lines on the 4-hour chart are currently trending downward, indicating a downturn. What is the next move for Solana? Solana’s price is currently falling. On the 4-hour chart, the cryptocurrency has dropped below the $150 support. The recent decline has breached the critical support level of $160, which had held since August 2. On the downside, the crypto signal is bearish, with the altcoin sliding to the bottom of the chart. Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement… The post Solana Slides To Its Lowest Price At $93 appeared on BitcoinEthereumNews.com. Nov 05, 2025 at 17:21 // Price Solana (SOL) price have fallen below the moving average lines after being rejected at the $200 level. SOL price long-term prediction: bearish  The negative trend has broken below both the moving average lines and the current support level of $170. The cryptocurrency has reached a low of $151. However, the price indicator suggests that the altcoin will continue to decline. SOL is expected to break below the current support level of $170 and fall as low as $130. A retraced candle body tested the 38.2% Fibonacci retracement level. The retracement indicates that Solana will fall to the 2.618 Fibonacci extension, or the $93.24 low. Technical indicators Key supply zones: $220, $240, $260 Key demand zones: $140, $120, $100 Solana price indicator analysis The moving average lines continue to slope lower as the coin declines further. The resistance line for the price bars is the 21-day SMA barrier. The horizontal moving average lines on the 4-hour chart are currently trending downward, indicating a downturn. What is the next move for Solana? Solana’s price is currently falling. On the 4-hour chart, the cryptocurrency has dropped below the $150 support. The recent decline has breached the critical support level of $160, which had held since August 2. On the downside, the crypto signal is bearish, with the altcoin sliding to the bottom of the chart. Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement…

Solana Slides To Its Lowest Price At $93

Nov 05, 2025 at 17:21 // Price

Solana (SOL) price have fallen below the moving average lines after being rejected at the $200 level.


SOL price long-term prediction: bearish 


The negative trend has broken below both the moving average lines and the current support level of $170. The cryptocurrency has reached a low of $151.


However, the price indicator suggests that the altcoin will continue to decline. SOL is expected to break below the current support level of $170 and fall as low as $130. A retraced candle body tested the 38.2% Fibonacci retracement level. The retracement indicates that Solana will fall to the 2.618 Fibonacci extension, or the $93.24 low.


Technical indicators


  • Key supply zones: $220, $240, $260



  • Key demand zones: $140, $120, $100


Solana price indicator analysis


The moving average lines continue to slope lower as the coin declines further. The resistance line for the price bars is the 21-day SMA barrier. The horizontal moving average lines on the 4-hour chart are currently trending downward, indicating a downturn.


What is the next move for Solana?


Solana’s price is currently falling. On the 4-hour chart, the cryptocurrency has dropped below the $150 support. The recent decline has breached the critical support level of $160, which had held since August 2. On the downside, the crypto signal is bearish, with the altcoin sliding to the bottom of the chart.


Disclaimer. This analysis and forecast are the personal opinions of the author. The data provided is collected by the author and is not sponsored by any company or token developer. This is not a recommendation to buy or sell cryptocurrency and should not be viewed as an endorsement by Coinidol.com. Readers should do their research before investing in funds.

Source: https://coinidol.com/solana-slides-lowest/

Market Opportunity
Solana Logo
Solana Price(SOL)
$142.22
$142.22$142.22
-0.89%
USD
Solana (SOL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26